New cell therapy shows promise to treat frailty among elderly, PgII

Key Highlights:

• A new international study shows promise in treating frailty among the elderly using mesenchymal stem cells.
• Participants aged 70-85 in the CRATUS trial showed a 20% improvement in physical endurance after a single infusion.
• The Lomecel-B (laromestrocel) stem cell product, developed by Longeveron, was used in the study.
• The study, published in Cell Stem Cell on March 5, indicates a potential treatment for accelerated aging.
• Frailty affects up to one in four people over 50 worldwide and is expected to rise in India.

Detailed Insights:

• Frailty is an accelerated biological aging condition marked by lower endurance and slower recovery, often undiagnosed and without standard treatment.
• Mesenchymal stem cells, found in bone marrow and fat tissue, can differentiate into various tissues and release molecules that reduce inflammation and promote tissue repair.
• The study found that laromestrocel potentially works by reducing inflammation in tissues surrounding small blood vessels.
• India's healthcare system is primarily focused on acute illness, with limited attention to preventive geriatric assessment and early interventions for aging-related vulnerabilities.
• Ayushman Bharat focuses on hospital-based care, and frailty is not recognized as a reimbursable condition, while the National Programme for Health Care of the Elderly has limited reach.
• The ICMR has issued strict guidelines limiting the use of stem cells to approved clinical trials to prevent exploitation by unregulated clinics.
• A therapy that improves resilience could significantly reduce hospital stays, complications, and improve the quality of life for elderly patients.

Key Concepts Involved:

• Frailty: A state of accelerated biological aging characterized by decreased endurance and slower recovery.
• Mesenchymal Stem Cells: Versatile cells found in bone marrow and fat tissue that can differentiate into various tissues and promote tissue repair.
• Ayushman Bharat: India's flagship public health insurance scheme focused on providing hospital-based secondary and tertiary care.